UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reversibility of chemotherapy-related liver injury

Journal of hepatology, 2017-07, Vol.67 (1), p.84-91

2017

Volltextzugriff (PDF)

Induction gemcitabine and oxaliplatin therapy followed by a twice‐weekly infusion of gemcitabine and concurrent external‐beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer

Cancer, 2013-01, Vol.119 (2), p.277-284

2013

Volltextzugriff (PDF)

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

BMC cancer, 2024-04, Vol.24 (1), p.436-436, Article 436

2024

Volltextzugriff (PDF)

Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer

HPB (Oxford, England), 2020-01, Vol.22 (1), p.116-123

2020

Volltextzugriff (PDF)

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients’ quality of life

Supportive care in cancer, 2019-12, Vol.27 (12), p.4697-4704

2019

Volltextzugriff (PDF)

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study

BMC cancer, 2024-05, Vol.24 (1), p.563-563, Article 563

2024

Volltextzugriff (PDF)

Second-line treatment options in hepatocellular carcinoma

Drugs in Context, 2019, Vol.8, p.212577-13

2019

Volltextzugriff (PDF)

Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival

Annals of surgical oncology, 2006-09, Vol.13 (9), p.1201-1208

2006

Volltextzugriff (PDF)

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

Exploration of targeted anti-tumor therapy, 2021-01, Vol.2 (5), p.448-464

2021

Volltextzugriff (PDF)

Integrating PROs into the clinic — overall survival benefit or not, it's worth the trouble

Nature reviews. Clinical oncology, 2017-09, Vol.14 (9), p.529-530

2017

Volltextzugriff (PDF)

Outcomes research: Integrating PROs into the clinic - overall survival benefit or not, it's worth the trouble

Nature reviews. Clinical oncology, 2017-09, Vol.14 (9), p.529-530

2017

Volltextzugriff (PDF)

Evolution of Long-Term Outcome of Liver Resection for Colorectal Metastases: Analysis of Actual 5-Year Survival Rates over Two Decades

Annals of surgical oncology, 2012-06, Vol.19 (6), p.2035-2044

2012

Volltextzugriff (PDF)

Telephone-based postoperative surveillance protocol for hepatobiliary cancer during the COVID-19 outbreak

Updates in surgery, 2020-06, Vol.72 (2), p.317-318

2020

Volltextzugriff (PDF)

Induction Gemcitabine and Oxaliplatin Therapy Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External-Beam Radiation for Neoadjuvant Treatment of Locally Advanced Pancreatic Cancer: A Single Institutional Experience

Cancer, 2013-01, Vol.119 (2), p.277-284

2013

Volltextzugriff (PDF)

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis

Critical reviews in oncology/hematology, 2018-04, Vol.124, p.21-28

2018

Volltextzugriff (PDF)

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study

BMC cancer, 2024-05, Vol.24 (1)

2024

Volltextzugriff (PDF)

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study

BMC cancer, 2024-04, Vol.24 (1)

2024

Volltextzugriff (PDF)

Colorectal Cancer with Synchronous Resectable Liver Metastases: Monocentric Management in a Hepatobiliary Referral Center Improves Survival Outcomes

Annals of surgical oncology, 2013-03, Vol.20 (3), p.938-945

2013

Volltextzugriff (PDF)

Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy?

Annals of surgical oncology, 2007-02, Vol.14 (2), p.766-770

2007

Volltextzugriff (PDF)

Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study

Annals of surgery, 2014-11, Vol.260 (5), p.878-885

2014

Volltextzugriff (PDF)

LDH as prognostic factor in second line treatment for advanced gastric cancer: The LINE study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16102-e16102

2021

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(63)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(34)
Humans
(23)
Oncology
(19)
Surgery
(18)
Female
(14)
Male
(14)
Aged
(13)
Middle Aged
(13)
Cancer
(12)
Adult
(11)
Prognosis
(10)
Tumors
(9)
Aged, 80 And Over
(8)
Colorectal Neoplasms - Pathology
(8)
Medicine
(8)
Medicine & Public Health
(8)
Patients
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Chemotherapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reversibility of chemotherapy-related liver injury

The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer

Induction gemcitabine and oxaliplatin therapy followed by a twice‐weekly infusion of gemcitabine and concurrent external‐beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients’ quality of life

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study

Second-line treatment options in hepatocellular carcinoma

Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival

CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

Integrating PROs into the clinic — overall survival benefit or not, it's worth the trouble

Outcomes research: Integrating PROs into the clinic - overall survival benefit or not, it's worth the trouble

Evolution of Long-Term Outcome of Liver Resection for Colorectal Metastases: Analysis of Actual 5-Year Survival Rates over Two Decades

Telephone-based postoperative surveillance protocol for hepatobiliary cancer during the COVID-19 outbreak

Induction Gemcitabine and Oxaliplatin Therapy Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External-Beam Radiation for Neoadjuvant Treatment of Locally Advanced Pancreatic Cancer: A Single Institutional Experience

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study

Colorectal Cancer with Synchronous Resectable Liver Metastases: Monocentric Management in a Hepatobiliary Referral Center Improves Survival Outcomes

Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy?

Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study

LDH as prognostic factor in second line treatment for advanced gastric cancer: The LINE study

Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients

Synaptophysin expression in mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis

Suchergebnisse filtern